naltrexone has been researched along with bd 1047 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, SS; Kamei, J; Ohsawa, M | 1 |
| Horishita, T; Inagaki, H; Kawasaki, T; Obara, G; Sata, T; Takahashi, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N | 1 |
2 other study(ies) available for naltrexone and bd 1047
| Article | Year |
|---|---|
Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice.
Topics: Administration, Topical; Animals; Diabetes Complications; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Naltrexone; Nitric Oxide; Pentazocine; Receptors, Opioid, kappa; Receptors, sigma; Sigma-1 Receptor | 2010 |
Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells.
Topics: Adrenal Medulla; Analgesics, Opioid; Animals; Cattle; Cell Line; Cell Membrane; Cells, Cultured; Ethylenediamines; Fluoxetine; Gene Expression; Humans; Naltrexone; Narcotic Antagonists; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pentazocine; Radionuclide Imaging | 2013 |